ArticleEcoHealth2026
Antibiotic Resistance and Virulence Genes in Escherichia coli from Wild Birds in a Peruvian Wetland.
Article in EcoHealth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The role of wildlife in carrying and disseminating resistant and pathogenic bacteria has been established, yet data from wildlife in Peru are limited. This study evaluated the antibiotic resistance, presence of virulence genes, and clonality of E. coli isolated from wild birds from wetlands in Lima, Peru. Twenty-three isolates were obtained from 41 free-living birds (belonging to 15 bird species) through cloacal and feather swabs (n = 30) and fresh feces (n = 11) collected in 2021. Nineteen pulsotypes were identified by Pulsed Field Gel Electrophoresis. High resistance rates were observed for tobramycin 60.9% (14/23) and ampicillin 52.2% (12/23). The resistance to sulfamethoxazole-trimethoprim was 26.1% (6/23) Lower resistance rates were observed for quinolones and cephalosporins, each with 17.4% (4/23) resistance. Multidrug resistance (MDR) was detected in 34.8% (8/23) of isolates, and 8.7% (2/23) were extended-spectrum beta lactamase (ESBL)-producing E. coli. (from Coragyps atratus (1/2 sampled 50%) and Phalacrocorax brasilianus (1/3 sampled 33.3%)) carrying bla
Indexed as
Identifiers
41963677What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.